Crystal structures of human transthyretin complexed with glabridin

Journal of Medicinal Chemistry

Volumn 57, Issue 3, 2014, Pages 1090-1096

  Yokoyama, Takeshi ^a   Kosaka, Yuto ^a   Mizuguchi, Mineyuki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; HUMANS; ISOFLAVONES; MODELS, MOLECULAR; PHENOLS; PREALBUMIN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION;

EID: 84894055771     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401832j     Document Type: Article

References (52)

1. Surguchev, A.; Surguchov, A. Conformational diseases: looking into the eyes Brain Res. Bull. 2010, 81, 12-24
2. Ando, Y.; Araki, S.; Ando, M. Transthyretin and familial amyloidotic polyneuropathy Intern. Med. 1993, 32, 920-922
3. Saraiva, M. J.; Costa, P. P.; Goodman, D. S. Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant J. Clin. Invest. 1985, 76, 2171-2177
4. Jacobson, D. R.; Pastore, R. D.; Yaghoubian, R.; Kane, I.; Gallo, G.; Buck, F. S.; Buxbaum, J. N. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans N. Engl. J. Med. 1997, 336, 466-473
5. Westermark, P.; Sletten, K.; Johansson, B.; Cornwell, G. G., 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 2843-2845
6. Buxbaum, J. N.; Tagoe, C. E. The genetics of the amyloidoses Annu. Rev. Med. 2000, 51, 543-569
7. Saraiva, M. J. Transthyretin mutations in health and disease Hum. Mutat. 1995, 5, 191-196
8. Bartalena, L.; Robbins, J. Thyroid hormone transport proteins Clin. Lab. Med. 1993, 13, 583-598
9. Foss, T. R.; Wiseman, R. L.; Kelly, J. W. The pathway by which the tetrameric protein transthyretin dissociates Biochemistry 2005, 44, 15525-15533
10. Kelly, J. W.; Colon, W.; Lai, Z.; Lashuel, H. A.; McCulloch, J.; McCutchen, S. L.; Miroy, G. J.; Peterson, S. A. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid Adv. Protein Chem. 1997, 50, 161-181
11. Hammarstrom, P.; Schneider, F.; Kelly, J. W. Trans-suppression of misfolding in an amyloid disease Science 2001, 293, 2459-2462
12. Miroy, G. J.; Lai, Z.; Lashuel, H. A.; Peterson, S. A.; Strang, C.; Kelly, J. W. Inhibiting transthyretin amyloid fibril formation via protein stabilization Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 15051-15056
13. Gordon, M. Dietary antioxidants in disease prevention Nat. Prod. Rep. 1996, 13, 265-273
14. Feskanich, D.; Ziegler, R. G.; Michaud, D. S.; Giovannucci, E. L.; Speizer, F. E.; Willett, W. C.; Colditz, G. A. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women J. Natl. Cancer Inst. 2000, 92, 1812-1823
15. Simmler, C.; Pauli, G. F.; Chen, S. N. Phytochemistry and biological properties of glabridin Fitoterapia 2013, 90C, 160-184
16. Adamski-Werner, S. L.; Palaninathan, S. K.; Sacchettini, J. C.; Kelly, J. W. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis J. Med. Chem. 2004, 47, 355-374
17. Bulawa, C. E.; Connelly, S.; Devit, M.; Wang, L.; Weigel, C.; Fleming, J. A.; Packman, J.; Powers, E. T.; Wiseman, R. L.; Foss, T. R.; Wilson, I. A.; Kelly, J. W.; Labaudiniere, R. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 9629-9634
18. Trivella, D. B.; dos Reis, C. V.; Lima, L. M.; Foguel, D.; Polikarpov, I. Flavonoid interactions with human transthyretin: combined structural and thermodynamic analysis J. Struct. Biol. 2012, 180, 143-153
19. Maia, F.; Almeida Mdo, R.; Gales, L.; Kijjoa, A.; Pinto, M. M.; Saraiva, M. J.; Damas, A. M. The binding of xanthone derivatives to transthyretin Biochem. Pharmacol. 2005, 70, 1861-1869
20. Radovic, B.; Hussong, R.; Gerhauser, C.; Meinl, W.; Frank, N.; Becker, H.; Kohrle, J. Xanthohumol, a prenylated chalcone from hops, modulates hepatic expression of genes involved in thyroid hormone distribution and metabolism Mol. Nutr. Food Res. 2010, 54 (Suppl 2) S225-235
21. Yazaki, K.; Sasaki, K.; Tsurumaru, Y. Prenylation of aromatic compounds, a key diversification of plant secondary metabolites Phytochemistry 2009, 70, 1739-1745
22. Green, N. S.; Foss, T. R.; Kelly, J. W. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 14545-14550
23. Sebaugh, J. L. Guidelines for accurate EC50/IC50 estimation Pharm. Stat. 2011, 10, 128-134
24. Klabunde, T.; Petrassi, H. M.; Oza, V. B.; Raman, P.; Kelly, J. W.; Sacchettini, J. C. Rational design of potent human transthyretin amyloid disease inhibitors Nat. Struct. Biol. 2000, 7, 312-321
25. Tojo, K.; Sekijima, Y.; Kelly, J. W.; Ikeda, S. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis Neurosci. Res. 2006, 56, 441-449
26. Castano, A.; Helmke, S.; Alvarez, J.; Delisle, S.; Maurer, M. S. Diflunisal for ATTR cardiac amyloidosis Congest. Heart Fail. 2012, 18, 315-319
27. Takeuchi, M.; Mizuguchi, M.; Kouno, T.; Shinohara, Y.; Aizawa, T.; Demura, M.; Mori, Y.; Shinoda, H.; Kawano, K. Destabilization of transthyretin by pathogenic mutations in the DE loop Proteins Struct. Funct. Bioinf. 2007, 66, 716-725
28. Yokoyama, T.; Mizuguchi, M.; Nabeshima, Y.; Kusaka, K.; Yamada, T.; Hosoya, T.; Ohhara, T.; Kurihara, K.; Tomoyori, K.; Tanaka, I.; Niimura, N. Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin J. Struct. Biol. 2012, 177, 283-290
29. Shinohara, Y.; Mizuguchi, M.; Matsubara, K.; Takeuchi, M.; Matsuura, A.; Aoki, T.; Igarashi, K.; Nagadome, H.; Terada, Y.; Kawano, K. Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy Biochemistry 2003, 42, 15053-15060
30. Koshland, D. E. Application of a theory of enzyme specificity to protein synthesis Proc. Natl. Acad. Sci. U.S.A. 1958, 44, 98-104
31. Tsai, C. J.; Kumar, S.; Ma, B.; Nussinov, R. Folding funnels, binding funnels, and protein function Protein Sci. 1999, 8, 1181-1190
32. Clemons, P. A.; Bodycombe, N. E.; Carrinski, H. A.; Wilson, J. A.; Shamji, A. F.; Wagner, B. K.; Koehler, A. N.; Schreiber, S. L. Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 18787-18792
33. Feng, L.; Geisselbrecht, Y.; Blanck, S.; Wilbuer, A.; Atilla-Gokcumen, G. E.; Filippakopoulos, P.; Kraling, K.; Celik, M. A.; Harms, K.; Maksimoska, J.; Marmorstein, R.; Frenking, G.; Knapp, S.; Essen, L. O.; Meggers, E. Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors J. Am. Chem. Soc. 2011, 133, 5976-5986
34. Niimura, N.; Bau, R. Neutron protein crystallography: beyond the folding structure of biological macromolecules Acta Crystallogr., A 2008, 64, 12-22
35. Banerjee, A.; Bairagya, H. R.; Mukhopadhyay, B. P.; Nandi, T. K.; Mishra, D. K. Conserved water mediated H-bonding dynamics of Ser117 and Thr119 residues in human transthyretin-thyroxin complexation: Inhibitor modeling study through docking and molecular dynamics simulation J. Mol. Graphics Modell. 2013, 44C, 70-80
36. Zanotti, G.; Cendron, L.; Folli, C.; Florio, P.; Imbimbo, B. P.; Berni, R. Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors FEBS Lett. 2013, 587, 2325-2331
37. Wiseman, R. L.; Johnson, S. M.; Kelker, M. S.; Foss, T.; Wilson, I. A.; Kelly, J. W. Kinetic stabilization of an oligomeric protein by a single ligand binding event J. Am. Chem. Soc. 2005, 127, 5540-5551
38. Matsubara, K.; Mizuguchi, M.; Kawano, K. Expression of a synthetic gene encoding human transthyretin in Escherichia coli Protein Expression Purif. 2003, 30, 55-61
39. Battye, T. G. G.; Kontogiannis, L.; Johnson, O.; Powell, H. R.; Leslie, A. G. W. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM Acta Crystallogr., Sect. D: Biol. Crystallogr. 2011, 67, 271-281
40. The CCP4 suite: programs for protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 1994, 50, 760-763.
41. Otwinowski, Z.; Minor, W. Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 1997, 276, 307-326
42. Irwin, J. J.; Shoichet, B. K. ZINC-a free database of commercially available compounds for virtual screening J. Chem. Inf. Model. 2005, 45, 177-182
43. Schuttelkopf, A. W.; van Aalten, D. M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 1355-1363
44. van Aalten, D. M.; Bywater, R.; Findlay, J. B.; Hendlich, M.; Hooft, R. W.; Vriend, G. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules J. Comput.-Aided Mol. Des. 1996, 10, 255-262
45. Adams, P. D.; Afonine, P. V.; Bunkoczi, G.; Chen, V. B.; Echols, N.; Headd, J. J.; Hung, L. W.; Jain, S.; Kapral, G. J.; Grosse Kunstleve, R. W.; McCoy, A. J.; Moriarty, N. W.; Oeffner, R. D.; Read, R. J.; Richardson, D. C.; Richardson, J. S.; Terwilliger, T. C.; Zwart, P. H. The Phenix software for automated determination of macromolecular structures Methods 2011, 55, 94-106
46. Adams, P. D.; Afonine, P. V.; Bunkoczi, G.; Chen, V. B.; Davis, I. W.; Echols, N.; Headd, J. J.; Hung, L. W.; Kapral, G. J.; Grosse-Kunstleve, R. W.; McCoy, A. J.; Moriarty, N. W.; Oeffner, R.; Read, R. J.; Richardson, D. C.; Richardson, J. S.; Terwilliger, T. C.; Zwart, P. H. PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 213-221
47. Emsley, P.; Cowtan, K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 2126-2132
48. Yang, H.; Guranovic, V.; Dutta, S.; Feng, Z.; Berman, H. M.; Westbrook, J. D. Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004, 60, 1833-1839
49. Brunger, A. T.; Adams, P. D.; Clore, G. M.; DeLano, W. L.; Gros, P.; Grosse-Kunstleve, R. W.; Jiang, J. S.; Kuszewski, J.; Nilges, M.; Pannu, N. S.; Read, R. J.; Rice, L. M.; Simonson, T.; Warren, G. L. Crystallography & NMR system: A new software suite for macromolecular structure determination Acta Crystallogr., Sect. D: Biol. Crystallogr. 1998, 54, 905-921
50. Brunger, A. T. Version 1.2 of the Crystallography and NMR system Nat. Protoc. 2007, 2, 2728-2733
51. McNicholas, S.; Potterton, E.; Wilson, K. S.; Noble, M. E. Presenting your structures: the CCP4mg molecular-graphics software Acta Crystallogr. Sect. D: Biol. Crystallogr. 2011, 67, 386-394
52. Schrodinger, LLC. The PyMOL Molecular Graphics System, Version 1.3r1, 2010.